ADC Therapeutics

ZYNLONTA

Manufacturer:

ADC Therapeutics

Name:

ZYNLONTA

Category:

J Code

HCPCS:

J9359

NDC(s):

79952-0110-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

ZYNLONTA is a Cancer drug manufactured by ADC Therapeutics and administered via the Intravenous route of administration. The J Code: J9359 is aligned to the drug ZYNLONTA.

Access Pricing and More By Registering